Australia Stock Exchange release from OPTHEA : Angiogenesis 2022 -Prof Cheung presentation of PCV data
13/02/2022 21:55
Australia Stock Exchange release from OPTHEA OPT.AX : Angiogenesis 2022 -Prof Cheung presentation of PCV data
Recent news on Opthea
See all newsBrief: Opthea To Recommence Trading On ASX On Or Around June 3, 2026
Brief: Opthea Says Hamish George Assumes Role Of CFO
Brief: Opthea Logs FY Prelim Loss Attributable $162.8 Mln
Australia's Opthea cuts 80% staff, key executives to exit in deal to avert bankruptcy (updated)
Brief: Opthea Says CEO Fred Guerard To Step Down